Loading data for RHHBF — first visit, this takes a few seconds.
Roche Holding AG (RHHBF)
OTC Markets OTCQX: RHHBF
· Real-Time Price · USD
441.39
+0.00 (0.00%)
At close: Sep 01, 2026, 10:00 AM
The price, the headline numbers and the latest news, in one place.
Roche Holding AG (RHHBF) Stock Price, Analysis & Data
0.00% (1D)
| Bid | 436 |
| Market Cap | 352B |
| Revenue (ttm) | 63B |
| Net Income (ttm) | 12.3B |
| 0.35 | |
| 18.89 | |
| 23.37 | |
| 29.74 | |
| P/B (ttm) | 8.75 |
| P/S (ttm) | 5.59 |
| Earnings Date | n/a |
| Ask | 471.26 |
| Volume | 3 |
| Avg. Volume (20D) | 104 |
| Open | 440.00 |
| Previous Close | 441.39 |
| Day's Range | 440.00 - 440.00 |
| 52-Week Range | 301.27 - 514.08 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $12.40 (2.81%) |
| Ex-Dividend Date | Mar 12, 2026 |
About RHHBF
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haematology, infectious diseases, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for ...
Industry Drug Manufacturers - General
Sector Healthcare
IPO Date Aug 3, 2012
Employees n/a
Stock Exchange OTC Markets OTCQX
Ticker Symbol RHHBF
Website https://www.roche.com
Financial Performance
In 2025, Roche's revenue was 63.36B, an increase of 1.54% compared to the previous year's 62.4B. Earnings were 12.88B, an increase of 55.61%.
Financial StatementsEarnings Surprise
Roche has released their quarterly earnings on Invalid Date:
- Revenue of n/a misses estimates by $0, with NaN% YoY growth.
- EPS of misses estimates by , with NaN% YoY growth.
Page 1 of 2